Shanghai StairMed Technology Co., Ltd.
PrivateLast Round
Strategic
Mar 12, 2026
Total Funding Raised
$120.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Shanghai StairMed Technology Co., Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Strategic round in March 2026.
Shanghai StairMed Technology Co., Ltd. is a therapeutic devices company that develops implantable brain-computer interface systems intended for motor control, neurological regulation, and sensory restoration.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Industrial Robotics
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai StairMed Technology Co., Ltd. Comparables
Compare Shanghai StairMed Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeuroXess | 92% | |
| BCIFlex | 89% | |
| NeuraMatrix | 88% |
For institutional investors. Book with your work email.
Shanghai StairMed Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Mar 12, 2026 | ||||
| Series B | Feb 10, 2025 | ||||
| Series A | Dec 30, 2022 | ||||
| Angel | Dec 21, 2022 |
For institutional investors. Book with your work email.
Shanghai StairMed Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yuanhe Capital | Series A |
| FountainBridge Capital | Strategic, Series B, Angel |
| SDIC Unity Capital | Strategic |
| Lapam Capital | Series B, Strategic |
| OrbiMed | Strategic, Series B, Series A |
| 上海国投先导私募基金管理有限公司 | Strategic |
| Yuanhe Origin | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 13, 2026
Hiring increased from 0 to 5 roles, representing 100% of headcount.
- Mar 12, 2026
$73M raised in a strategic round.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingOct 29, 2026
Stairmed raises about $210M in H2 '26.
- is_developingSep 3, 2026
Stairmed is developing a working BCI implant in China and is still testing it after the NMPA approves its micro-electrode driver in Jun '26, with 18 patients receiving the implant by Jul '26.
- is_developingAug 14, 2026
Stairmed is developing the experimental system with researchers from the Chinese Academy of Sciences; it could potentially guide a brain implant through blood vessels in the neck without opening the skull, but it remains experimental in China as of Aug 14th '26.
- identified_as_competitor_ofAug 10, 2026
Stairmed is identified as a potential competitor to Neuralink in China’s brain-computer interface market, as its vein-based implant targets 10-minute placement versus roughly two hours for Neuralink’s surgery, according to the South China Morning Post, though it has not entered human trials.
- is_developingAug 9, 2026
Stairmed is developing 'minimally invasive' (less incision) technology in China that reaches the brain directly through the blood veins in the neck, according to an Aug 9th '26 report.
For institutional investors. Book with your work email.
Shanghai StairMed Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shanghai StairMed Technology Co., Ltd.'s valuation, stock price, and market status.
Is Shanghai StairMed Technology Co., Ltd. a public or private company?
Shanghai StairMed Technology Co., Ltd. is a private company.
What is the current stock price of Shanghai StairMed Technology Co., Ltd.?
Shanghai StairMed Technology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Shanghai StairMed Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shanghai StairMed Technology Co., Ltd. worth (valuation)?
Valuation information for Shanghai StairMed Technology Co., Ltd. is not publicly available.
Can I buy Shanghai StairMed Technology Co., Ltd. stock?
Shanghai StairMed Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shanghai StairMed Technology Co., Ltd.'s last funding round?
Shanghai StairMed Technology Co., Ltd.'s most recent funding round was Strategic on March 12, 2026.
Who are the main investors in Shanghai StairMed Technology Co., Ltd.?
Key investors in Shanghai StairMed Technology Co., Ltd. include Yuanhe Capital, Lapam Capital, OrbiMed, Yuanhe Origin, Lilly Asia Ventures.
Will Shanghai StairMed Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Shanghai StairMed Technology Co., Ltd..
How can I track Shanghai StairMed Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Shanghai StairMed Technology Co., Ltd.'s shares on secondary markets.